Agendia unveils ColoPrint microarray signature
07:25 EDT 4 Jun 2012 | Pharmaceutical Business Review
Agendia, a developer of genomic-based diagnostic products, has unveiled ColoPrint microarray-based 18-gene expression signature.
Original Article: Agendia unveils ColoPrint microarray signature
More From BioPortfolio on "Agendia unveils ColoPrint microarray signature"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
